These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38504847)

  • 1. Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma.
    Pothuri VS; Hogg GD; Conant L; Borcherding N; James CA; Mudd J; Williams G; Seo YD; Hawkins WG; Pillarisetty VG; DeNardo DG; Fields RC
    Oncoimmunology; 2024; 13(1):2320411. PubMed ID: 38504847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
    Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
    Front Immunol; 2021; 12():730746. PubMed ID: 34630409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma.
    Pan Y; Gao J; Lin J; Ma Y; Hou Z; Lin Y; Wen S; Pan M; Lu F; Huang H
    Front Endocrinol (Lausanne); 2023; 14():1181538. PubMed ID: 37347110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application.
    Wang X; Dai Z; Lin X; Zou X; Wang R; Tasiheng Y; Yan Y; Ma M; Chen Y; Cheng H; Liu C; Yu X
    Cancer Lett; 2024 Apr; 588():216741. PubMed ID: 38395378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-based identification of tumor-reactive and bystander CD8
    Meng Z; Rodriguez Ehrenfried A; Tan CL; Steffens LK; Kehm H; Zens S; Lauenstein C; Paul A; Schwab M; Förster JD; Salek M; Riemer AB; Wu H; Eckert C; Leonhardt CS; Strobel O; Volkmar M; Poschke I; Offringa R
    Sci Transl Med; 2023 Nov; 15(722):eadh9562. PubMed ID: 37967201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
    Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
    Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.
    Schina A; Sztupinszki Z; Marie Svane I; Szallasi Z; Jönsson G; Donia M
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.
    Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X
    Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma.
    Hopkins AC; Yarchoan M; Durham JN; Yusko EC; Rytlewski JA; Robins HS; Laheru DA; Le DT; Lutz ER; Jaffee EM
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors.
    Li X; Zhang Y; Guo S; Wu Z; Wang H; Huang Y; Wang Y; Qiu M; Lang J; Xiao Y; Zhu Y; Jin G; Hu L; Kong X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):129. PubMed ID: 38488909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC.
    Wang J; Zhang T; Li P; Gai J; Chen S; Espinoza G; Kung HC; Zhang R; Fujiwara K; Fu J; Yu J; Zheng L
    Cancer Lett; 2023 Oct; 573():216366. PubMed ID: 37640197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with less HIV quasispecies diversity.
    Pilkinton MA; McDonnell WJ; Barnett L; Chopra A; Gangula R; White KD; Leary S; Currenti J; Gaudieri S; Mallal SA; Kalams SA
    J Virol; 2021 Mar; 95(8):. PubMed ID: 33536169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma.
    Zheng H; Li Y; Zhao Y; Jiang A
    Sci Rep; 2023 Mar; 13(1):3684. PubMed ID: 36878969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.